Humacyte, Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript November 12, 2025
Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.17.
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte’s Third Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I’ll now turn the call over to Tom Johnson with LifeSci Advisors. Please go ahead.
Thomas Johnson: Thank you, operator. Before...
